L Capital Asia invests $25m in Taiwan skincare brand

Founded in 2003 by dermatologist Dr. Yin-Ching Wu, the company offers products addressing issues such as dry skin, with an emphasis on not using additives or alcohol. Headquartered in Taipei, Dr.Wu has 1,200 point-of-sales networks across seven countries.

L Capital Asia will help the company further develop its retail operations and product design, while offering access to international markets.

"We are excited at this opportunity to be partnering a category leader like Dr.Wu from a fairly well-developed and competitive market like Taiwan," said Ravi Thakran, managing partner of L Capital Asia. "I firmly believe that the combination of Dr. Wu's strong product knowledge and well-established brand name, with our insights on marketing as well as our market access will make for a good case study for international market expansion."

This is not L Capital's first investment in skincare and cosmetic segment in Asia. Last July, it invested in Guangdong Marubi Biological Technoloy Stock, becoming the second-largest shareholder in the cosmetics company. The deal was reportedly worth more than $100 million.

Hanji Huang, managing director of the firm, told AVCJ at the time that he saw strong potential growth in this segment, particularly among East Asian females who are willing to spend more on cosmetics.

L Capital Asia reached a first close on its second regional fund last September at the hard cap of $950 million after less than six months in the market. The final close, which included the GP commitment, followed a few months later.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Save this article  
• Send to  

• Topics
• Greater China
• Consumer
• Expansion
• Taiwan (China)
• L Capital Asia
• Consumer
• Growth capital